Massachusetts Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-116,564
| Closed | -$7.86M | – | 807 |
|
|
2019
Q3 | $7.86M | Sell |
116,564
-213,665
| -65% | -$14.4M | ﹤0.01% | 625 |
|
|
2019
Q2 | $28.3M | Sell |
330,229
-830,717
| -72% | -$71.2M | 0.01% | 483 |
|
|
2019
Q1 | $103M | Buy |
1,160,946
+56,500
| +5% | +$5.02M | 0.04% | 282 |
|
|
2018
Q4 | $94M | Buy |
1,104,446
+106,391
| +11% | +$9.06M | 0.05% | 271 |
|
|
2018
Q3 | $96.8M | Buy |
998,055
+29,852
| +3% | +$2.89M | 0.04% | 296 |
|
|
2018
Q2 | $91.2M | Buy |
968,203
+8,282
| +0.9% | +$780K | 0.04% | 296 |
|
|
2018
Q1 | $77.8M | Buy |
959,921
+15,213
| +2% | +$1.23M | 0.03% | 318 |
|
|
2017
Q4 | $84.2M | Buy |
944,708
+28,383
| +3% | +$2.53M | 0.04% | 313 |
|
|
2017
Q3 | $85.3M | Sell |
916,325
-28,756
| -3% | -$2.68M | 0.04% | 300 |
|
|
2017
Q2 | $85.8M | Buy |
945,081
+28,685
| +3% | +$2.61M | 0.04% | 283 |
|
|
2017
Q1 | $80.4M | Buy |
916,396
+41,176
| +5% | +$3.61M | 0.04% | 290 |
|
|
2016
Q4 | $72.5M | Buy |
875,220
+60,152
| +7% | +$4.98M | 0.04% | 298 |
|
|
2016
Q3 | $75.4M | Buy |
+815,068
| New | +$75.4M | 0.04% | 280 |
|